Mailing Address:
UCLA Semel 760 Westwood Plaza, Room 37-452 Los Angeles, CA 90095 UNITED STATES
|
|
|
Kerber Kevin Brian, Wisniewski Stephen R, Luther James F, Leuchter Andrew F, D'Empaire Inna, Trivedi Madhukar H, Rush A John Effects of heart disease on depression treatment: results from the
COMED study..
General hospital psychiatry.
2012; 34(1):
24-34.
Leuchter Andrew F, Cook Ian A, Hunter Aimee M, Cai Chaochao, Horvath Steve Resting-state quantitative electroencephalography reveals increased
neurophysiologic connectivity in depression..
PloS one.
2012; 7(2):
e32508.
Korb Alexander S, Hunter Aimee M, Cook Ian A, Leuchter Andrew F Rostral anterior cingulate cortex activity and early symptom
improvement during treatment for major depressive disorder..
Psychiatry research.
2011; 192(3):
188-94.
Muthén Bengt, Asparouhov Tihomir, Hunter Aimee M, Leuchter Andrew F Growth modeling with nonignorable dropout: alternative analyses of the
STAR*D antidepressant trial..
Psychological methods.
2011; 16(1):
17-33.
Leuchter Andrew F, Cook Ian A, Hamilton Steven P, Narr Katherine L, Toga Arthur, Hunter Aimee M, Faull Kym, Whitelegge Julian, Andrews Anne M, Loo Joseph, Way Baldwin, Nelson Stanley F, Horvath Steven, Lebowitz Barry D Biomarkers to predict antidepressant response..
Current psychiatry reports.
2010; 12(6):
553-62.
Hunter Aimee M, Cook Ian A, Leuchter Andrew F Impact of antidepressant treatment history on clinical outcomes in
placebo and medication treatment of major depression..
Journal of clinical psychopharmacology.
2010; 30(6):
748-51.
Hunter Aimee, Bordelon Yvette, Cook Ian, Leuchter Andrew QEEG Measures in Huntington's Disease: A Pilot Study..
PLoS currents.
2010; 2(6):
RRN1192.
Warden Diane, Trivedi Madhukar H, Wisniewski Stephen R, Kurian Benji, Zisook Sidney, Kornstein Susan G, Friedman Edward S, Miyahara Sachiko, Leuchter Andrew F, Fava Maurizio, Rush A John Early adverse events and attrition in selective serotonin reuptake
inhibitor treatment: a suicide assessment methodology study report..
Journal of clinical psychopharmacology.
2010; 30(3):
259-66.
Kobak Kenneth A, Leuchter Andrew, DeBrota David, Engelhardt Nina, Williams Janet B W, Cook Ian A, Leon Andrew C, Alpert Jonathan Site versus centralized raters in a clinical depression trial: impact
on patient selection and placebo response..
Journal of clinical psychopharmacology.
2010; 30(2):
193-7.
Hunter Aimee M, Muthén Bengt O, Cook Ian A, Leuchter Andrew F Antidepressant response trajectories and quantitative
electroencephalography (QEEG) biomarkers in major depressive disorder..
Journal of psychiatric research.
2010; 44(2):
90-8.
Cook Ian A, Hunter Aimee M, Abrams Michelle, Siegman Barbara, Leuchter Andrew F Midline and right frontal brain function as a physiologic biomarker of
remission in major depression..
Psychiatry research.
2009; 174(2):
152-7.
Leuchter Andrew F, Cook Ian A, Marangell Lauren B, Gilmer William S, Burgoyne Karl S, Howland Robert H, Trivedi Madhukar H, Zisook Sidney, Jain Rakesh, McCracken James T, Fava Maurizio, Iosifescu Dan, Greenwald Scott Comparative effectiveness of biomarkers and clinical indicators for
predicting outcomes of SSRI treatment in Major Depressive Disorder:
results of the BRITE-MD study..
Psychiatry research.
2009; 169(2):
124-31.
Leuchter Andrew F, Cook Ian A, Gilmer William S, Marangell Lauren B, Burgoyne Karl S, Howland Robert H, Trivedi Madhukar H, Zisook Sidney, Jain Rakesh, Fava Maurizio, Iosifescu Dan, Greenwald Scott Effectiveness of a quantitative electroencephalographic biomarker for
predicting differential response or remission with escitalopram and
bupropion in major depressive disorder..
Psychiatry research.
2009; 169(2):
132-8.
Leuchter Andrew F, McCracken James T, Hunter Aimee M, Cook Ian A, Alpert Jonathan E Monoamine oxidase a and catechol-o-methyltransferase functional
polymorphisms and the placebo response in major depressive disorder..
Journal of clinical psychopharmacology.
2009; 29(4):
372-7.
Hunter Aimee M, Leuchter Andrew F, Cook Ian A, Abrams Michelle, Siegman Barbara E, Furst Daniel E, Chappell Amy S Brain functional changes and duloxetine treatment response in
fibromyalgia: a pilot study..
Pain medicine (Malden, Mass.).
2009; 10(4):
730-8.
Kalechstein Ari D, De la Garza Richard, Newton Thomas F, Green Michael F, Cook Ian A, Leuchter Andrew F Quantitative EEG abnormalities are associated with memory impairment
in recently abstinent methamphetamine-dependent individuals..
The Journal of neuropsychiatry and clinical neurosciences.
2009; 21(3):
254-8.
Leuchter Andrew F, Cook Ian A, Hunter Aimee M, Korb Alexander S A new paradigm for the prediction of antidepressant treatment
response..
Dialogues in clinical neuroscience.
2009; 11(4):
435-46.
Korb Alexander S, Cook Ian A, Hunter Aimee M, Leuchter Andrew F Brain electrical source differences between depressed subjects and
healthy controls..
Brain topography.
2008; 21(2):
138-46.
Leuchter Andrew F, Lesser Ira M, Trivedi Madhukar H, Rush A John, Morris David W, Warden Diane, Fava Maurizio, Wisniewski Stephen R, Luther James F, Perales Mercedes, Gaynes Bradley N, Stewart Jonathan W An open pilot study of the combination of escitalopram and
bupropion-SR for outpatients with major depressive disorder..
Journal of psychiatric practice.
2008; 14(5):
271-80.
Fava Maurizio, Rush A John, Alpert Jonathan E, Balasubramani G K, Wisniewski Stephen R, Carmin Cheryl N, Biggs Melanie M, Zisook Sidney, Leuchter Andrew, Howland Robert, Warden Diane, Trivedi Madhukar H Difference in treatment outcome in outpatients with anxious versus
nonanxious depression: a STAR*D report..
The American journal of psychiatry.
2008; 165(3):
342-51.
Leuchter Andrew, Levey Gerald S Need to strike balance with industry-academia rules..
Nature.
2007; 449(7163):
658.
Cook Ian A, Bookheimer Susan Y, Mickes Laura, Leuchter Andrew F, Kumar Anand Aging and brain activation with working memory tasks: an fMRI study of
connectivity..
International journal of geriatric psychiatry.
2007; 22(4):
332-42.
Hunter Aimee M, Cook Ian A, Leuchter Andrew F The promise of the quantitative electroencephalogram as a predictor of
antidepressant treatment outcomes in major depressive disorder..
The Psychiatric clinics of North America.
2007; 30(1):
105-24.
Claassen Cynthia A, Trivedi Madhukar H, Rush A John, Husain Mustafa M, Zisook Sidney, Young Elizabeth, Leuchter Andrew, Wisniewski Stephen R, Balasubramani G K, Alpert Jonathan Clinical differences among depressed patients with and without a
history of suicide attempts: findings from the STAR*D trial..
Journal of affective disorders.
2007; 97(1-3):
77-84.
Morgan Melinda L, Cook Ian A, Rapkin Andrea J, Leuchter Andrew F Neurophysiologic changes during estrogen augmentation in
perimenopausal depression..
Maturitas.
2007; 56(1):
54-60.
Hunter Aimee M, Leuchter Andrew F, Morgan Melinda L, Cook Ian A Changes in brain function (quantitative EEG cordance) during placebo
lead-in and treatment outcomes in clinical trials for major
depression..
The American journal of psychiatry.
2006; 163(8):
1426-32.
Moses Tally, Leuchter Andrew F, Cook Ian, Abrams Michelle Does the clinical course of depression determine improvement in
symptoms and quality of life?.
The Journal of nervous and mental disease.
2006; 194(4):
241-8.
Venneman Sandy, Leuchter Andrew, Bartzokis George, Beckson Mace, Simon Sara L, Schaefer Melodie, Rawson Richard, Newton Tom, Cook Ian A, Uijtdehaage Sebastian, Ling Walter Variation in neurophysiological function and evidence of quantitative
electroencephalogram discordance: predicting cocaine-dependent
treatment attrition..
The Journal of neuropsychiatry and clinical neurosciences.
2006; 18(2):
208-16.
Cook Ian A, Leuchter Andrew F, Morgan Melinda L, Stubbeman William, Siegman Barbara, Abrams Michelle Changes in prefrontal activity characterize clinical response in SSRI
nonresponders: a pilot study..
Journal of psychiatric research.
2005; 39(5):
461-6.
Krell Heather V, Leuchter Andrew F, Cook Ian A, Abrams Michelle Evaluation of reboxetine, a noradrenergic antidepressant, for the
treatment of fibromyalgia and chronic low back pain..
Psychosomatics.
2005; 46(5):
379-84.
Lesser Ira M, Leuchter Andrew F, Trivedi Madhukar H, Davis Lori L, Wisniewski Stephen R, Balasubramani G K, Petersen Timothy, Stegman Diane, Rush A John Characteristics of insured and noninsured outpatients with depression
in STAR(*)D..
Psychiatric services (Washington, D.C.).
2005; 56(8):
995-1004.
Morgan Melinda L, Cook Ian A, Rapkin Andrea J, Leuchter Andrew F Estrogen augmentation of antidepressants in perimenopausal depression:
a pilot study..
The Journal of clinical psychiatry.
2005; 66(6):
774-80.
Morgan Melinda L, Witte Elise A, Cook Ian A, Leuchter Andrew F, Abrams Michelle, Siegman Barbara Influence of age, gender, health status, and depression on
quantitative EEG..
Neuropsychobiology.
2005; 52(2):
71-6.
Leuchter Andrew F, Morgan Melinda, Cook Ian A, Dunkin Jennifer, Abrams Michelle, Witte Elise Pretreatment neurophysiological and clinical characteristics of
placebo responders in treatment trials for major depression..
Psychopharmacology.
2004; 177(1-2):
15-22.
Stubbeman William F, Leuchter Andrew F, Cook Ian A, Shurman Brett D, Morgan Melinda, Gunay Ibrahim, Gonzalez Sergio Pretreatment neurophysiologic function and ECT response in depression..
The journal of ECT.
2004; 20(3):
142-4.
Krell Heather V, Leuchter Andrew F, Morgan Melinda, Cook Ian A, Abrams Michelle Subject expectations of treatment effectiveness and outcome of
treatment with an experimental antidepressant..
The Journal of clinical psychiatry.
2004; 65(9):
1174-9.
Cook Ian A, Leuchter Andrew F, Morgan Melinda L, Dunkin Jennifer J, Witte Elise, David Steven, Mickes Laura, O'Hara Ruth, Simon Sara, Lufkin Robert, Abrams Michelle, Rosenberg Susan Longitudinal progression of subclinical structural brain disease in
normal aging..
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
2004; 12(2):
190-200.
Marie-Mitchell Ariane, Leuchter Andrew F, Chou Chih-Ping, James Gauderman W, Azen Stanley P Predictors of improved mood over time in clinical trials for major
depression..
Psychiatry research.
2004; 127(1-2):
73-84.
Cook Ian A, Leuchter Andrew F, Morgan Melinda L, Conlee Elise Witte, David Steven, Lufkin Robert, Babaie Ashkan, Dunkin Jennifer J, O'Hara Ruth, Simon Sara, Lightner Amy, Thomas Susan, Broumandi David, Badjatia Neeraj, Mickes Laura, Mody Rajal K, Arora Sanjaya, Zheng Zimu, Abrams Michelle, Rosenberg-Thompson Susan Cognitive and physiologic correlates of subclinical structural brain
disease in elderly healthy control subjects..
Archives of neurology.
2002; 59(10):
1612-20.
Cook Ian A, Morgan Melinda L, Dunkin Jennifer J, David Steven, Witte Elise, Lufkin Robert, Abrams Michelle, Rosenberg Susan, Leuchter Andrew F Estrogen replacement therapy is associated with less progression of
subclinical structural brain disease in normal elderly women: a pilot
study..
International journal of geriatric psychiatry.
2002; 17(7):
610-8.
Leuchter Andrew F, Cook Ian A, Witte Elise A, Morgan Melinda, Abrams Michelle Changes in brain function of depressed subjects during treatment with
placebo..
The American journal of psychiatry.
2002; 159(1):
122-9.
|
|
|